NCT06195527View on ClinicalTrials.gov

PEMBRO-K : Evaluation of Pembrolizumab Therapeutic Pharmacological Monitoring Benefit in NSCLC

Not yet recruitingOBSERVATIONAL

Enrollment

75

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

February 1, 2028

Study Completion Date

February 1, 2028

Conditions

Non Small Cell Lung Cancer

Trial Locations (2)

49000

Angers University Hospital, Angers

53000

CH Le Mans, Le Mans

All Listed Sponsors

lead

University Hospital, Angers

OTHER_GOV